Heart failure imaging patterns in systemic lupus erythematosus. Evaluation using cardiovascular magnetic resonance

International Journal of Cardiology

Volumn 176, Issue 2, 2014, Pages 559-561

  Mavrogeni, Sophie ^a   Karabela, Georgia ^b   Stavropoulos, Efthymios ^b   Plastiras, Sotiris ^a   Spiliotis, George ^b   Gialafos, Elias ^c   Kolovou, Genovefa ^a   Sfikakis, Petros P ^c   Kitas, George D ^d  

^a ONASSIS CARDIAC SURGERY CENTER   (Greece)

^b ATHENS NAVAL HOSPITAL   (Greece)

^c UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^d UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Cardiac magnetic resonance; Coronary artery disease; Microvascular dysfunction; Myocarditis; Valvular disease

Indexed keywords

GADOLINIUM;

ADULT; AORTA VALVE STENOSIS; CARDIOVASCULAR MAGNETIC RESONANCE; CLINICAL ARTICLE; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; EARLY DIAGNOSIS; ENDOCARDIAL DISEASE; ENDOCARDITIS; FEMALE; HEART FAILURE; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART LEFT VENTRICLE ENDSYSTOLIC VOLUME; HEART LEFT VENTRICLE FAILURE; HEART MUSCLE FIBROSIS; HUMAN; IMAGE ANALYSIS; IMAGE ENHANCEMENT; INCIDENCE; LETTER; LIBMAN SACKS ENDOCARDITIS; MALE; MITRAL VALVE REGURGITATION; MYOCARDITIS; SYSTEMIC LUPUS ERYTHEMATOSUS; VASCULITIS; EVALUATION STUDY; LUPUS ERYTHEMATOSUS, SYSTEMIC; NUCLEAR MAGNETIC RESONANCE IMAGING; STANDARDS; UTILIZATION; YOUNG ADULT;

ADULT; FEMALE; HEART FAILURE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MAGNETIC RESONANCE IMAGING, CINE; MALE; YOUNG ADULT;

EID: 84922406419     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2014.07.016     Document Type: Article

References (16)

1. van der Laan-Baalbergen NE, Mollema SA, Kritikos H, et al. Heart failure as presenting manifestation of cardiac involvement in systemic lupus erythematosus. Neth J Med 2009; 67: 295-301.
2. Mavrogeni S, Sfikakis PP, Gialafos E, et al. Cardiac tissue characterization and the diagnostic value of cardiovascular magnetic resonance in systemic connective tissue diseases. Arthritis Care Res (Hoboken) 2014; 66(1): 104-12.
3. Pons-Estel GJ, González LA, Zhang J, et al. Predictors of cardiovascular damage in patients with systemic lupus erythematosus: Data from LUMINA (LXVIII), a multiethnic US cohort. Rheumatology (Oxford) 2009; 48(7): 817-22.
4. Schoenfeld SR, Kasturi S, Costenbader KH. The epidemiology of atherosclerotic cardiovascular disease among patients with SLE: A systematic review. Semin Arthritis Rheum 2013; 43(1): 77-95.
5. Mavrogeni S, Bratis K, Markussis V, et al. The diagnostic role of cardiac magnetic resonance imaging in detecting myocardial inflammation in systemic lupus erythematosus. Differentiation from viral myocarditis. Lupus 2013; 22(1): 34-43.
6. Mavrogeni S, Spargias K,Markussis V, et al. Myocardial inflammation in autoimmune diseases: Investigation by cardiovascular magnetic resonance and endomyocardial biopsy. Inflamm Allergy Drug Targets 2009; 8(5): 390-7.
7. Apte M, McGwin Jr. G, Vilá LM, et al. Associated factors and impact of myocarditis in patients with SLE from LUMINA, a multiethnic US cohort (LV). Rheumatology (Oxford) 2008; 47(3): 362-7.
8. Nicklin A, Byard RW. Lethal manifestations of systemic lupus erythematosus in a forensic context. J Forensic Sci 2011; 56(2): 423-8.
9. Sung JM, Hsu SC, Chen FF, Huang JJ. Systemic lupus erythematosus presented as non-inflammatory necrotizing vasculopathy-induced ischemic glomerulopathy and small vessels-related ischemic cardiomyopathy. Lupus 2002; 11(7): 458-62.
10. Raman SV, Aneja A, Jarjour WN. CMR in inflammatory vasculitis. J Cardiovasc Magn Reson 2012; 14: 82.
11. Mavrogeni S, Cantini F, Pohost GM. Systemic vasculitis: An underestimated cause of heart failure-Assessment by cardiovascular magnetic resonance. Rev Cardiovasc Med 2013; 14(1): 49-55.
12. Moyssakis I, Tektonidou MG, Vasilliou VA, Samarkos M, Votteas V, Moutsopoulos HM. Libman-Sacks endocarditis in systemic lupus erythematosus: Prevalence, associations, and evolution. Am J Med 2007; 120(7): 636-42.
13. Reynolds JA, Robertson AC, Bruce IN, Alexander MY. Improving cardiovascular outcomes in rheumatic diseases: Therapeutic potential of circulating endothelial progenitor cells. Pharmacol Ther 2014; 142(2): 231-43.
14. Braun-Moscovici Y, Butbul-Aviel Y, Guralnik L, et al. Rituximab: Rescue therapy in life-Threatening complications or refractory autoimmune diseases: A single center experience. Rheumatol Int 2013; 33(6): 1495-504.
15. Roes SD, Kelle S, Kaandorp TA, et al. Comparison ofmyocardial infarct size assessed with contrast-enhanced magnetic resonance imaging and left ventricular function and volumes to predict mortality in patients with healed myocardial infarction. Am J Cardiol 2007; 100: 930-6.
16. Scott PA, Morgan JM, Carroll N, et al. The extent of left ventricular scar quantified by late gadolinium enhancement MRI is associated with spontaneous ventricular arrhythmias in patients with coronary artery disease and implantable cardioverter-defibrillators. Circ Arrhythm Electrophysiol 2011; 4(3): 324-30.